SQUAMOUS CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR lung cancer trial pulled before it even started
Disease control TerminatedThis trial aimed to test a new treatment for people with metastatic non-small cell lung cancer. Doctors would take immune cells from a patient's tumor, use CRISPR gene editing to make them stronger, and then put them back into the patient. The goal was to see if these edited cell…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
Precision radiation boost shows promise for tough lung cancers
Disease control OngoingThis study tested a new way of giving radiation therapy (called image-guided hypofractionated radiotherapy with a stereotactic boost) along with standard chemotherapy for people with stage II-III non-small cell lung cancer that cannot be removed by surgery. The goal was to find t…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Custom-Made vaccine targets tough cancers in early trial
Disease control TerminatedThis early-phase trial tested a personalized vaccine (PANDA-VAC) made from a patient's own tumor markers, given alongside the immunotherapy drug pembrolizumab. It involved 6 adults with advanced squamous lung or head/neck cancers that could not be cured. The main goal was to chec…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New hope for hard-to-treat cancers: experimental drug enters human testing
Disease control OngoingThis early-stage study tests a new drug called TT125-802 in about 50 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. Researchers will also watch for signs that the drug sh…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated May 06, 2026 16:02 UTC